iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)
Clinical trial NCT06560333 · WITHDRAWN
Trial details
- NCT number
- NCT06560333
- Sponsor
- Eurofarma Laboratorios S.A.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-30
- Primary completion
- 2027-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.